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Abstract
A central question in genomic imprinting is how parental-specific DNA methylation of imprinting control regions (ICR) is
established during gametogenesis and maintained after fertilization. At the imprinted Igf2/H19 locus, CTCF binding
maintains the unmethylated state of the maternal ICR after the blastocyst stage. In addition, evidence from Beckwith-
Wiedemann patients and cultured mouse cells suggests that two Sox-Oct binding motifs within the Igf2/H19 ICR also
participate in maintaining hypomethylation of the maternal allele. We found that the Sox and octamer elements from both
Sox-Oct motifs were required to drive hypomethylation of integrated transgenes in mouse embryonic carcinoma cells. Oct4
and Sox2 showed cooperative binding to the Sox-Oct motifs, and both were present at the endogenous ICR. Using a mouse
with mutations in the Oct4 binding sites, we found that maternally transmitted mutant ICRs acquired partial methylation in
somatic tissues, but there was little effect on imprinted expression of H19 and Igf2. A subset of mature oocytes also showed
partial methylation of the mutant ICR, which suggested that the Sox-Oct motifs provide some protection from methylation
during oogenesis. The Sox-Oct motifs, however, were not required for erasure of paternal methylation in primordial germ
cells, which indicated that the oocyte methylation was acquired post-natally. Maternally inherited mutant ICRs were
unmethylated in blastocysts, which suggested that at least a portion of the methylation in somatic tissues occurred after
implantation. These findings provide evidence that Sox-Oct motifs contribute to ICR hypomethylation in post-implantation
embryos and maturing oocytes and link imprinted DNA methylation with key stem cell/germline transcription factors.
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Introduction
Genomic imprinting is an epigenetic phenomenon that employs
DNA methylation to direct unequal expression of the two parental
alleles of a gene. Genes subject to genomic imprinting are
characterized by sequences known as differentially methylated
regions (DMRs), which are methylated only on the maternal allele
for some imprinted genes, and only on the paternal allele for
others. A subset of DMRs are the key elements directing mono-
allelic transcription of one or more imprinted genes and are often
termed ‘imprinting control regions’ (ICRs). Their parental-specific
DNA methylation imprints generally are established during
oogenesis or spermatogenesis and are maintained after fertilization
in somatic cell lineages. ICRs regulate transcription of imprinted
genes by several mechanisms, including methylation-dependent
repression, expression of non-coding RNAs, and long-range
chromatin interactions [1]. In addition to DNA methylation,
certain histone modifications are frequently associated with ICRs,
and there is evidence that they also can act as an imprint [2].
An ICR upstream of the H19 gene on mouse chromosome 7
and on human chromosome 11p15 coordinates the reciprocal
expression of H19 and Igf2 by controlling access to shared
enhancers. Methylation differences between the parental alleles
are established in the gametes, as CpGs within the Igf2/H19 ICR
are hypomethylated in oocytes and hypermethylated in sperm.
After fertilization, this differential methylation is maintained in
essentially all somatic cells. To direct imprinted expression of Igf2,
the ICR acts as a CTCF-dependent chromatin boundary or
insulator that blocks interaction of the Igf2 promoter with
downstream enhancers through the formation of cohesin-depen-
dent intra-chromosomal loops [3–5]. Conversely, hypermethyla-
tion of the paternal ICR represses H19 expression and blocks
CTCF binding, which allows interaction of the enhancers with the
Igf2 promoter via an alternative loop structure [6–8]. Consistent
with this model, deletion of the ICR or mutation of the CTCF sites
in mice results in biallelic expression of Igf2 [9–11]. The
imprinting mechanism appears to be the same in humans, as
some patients with Beckwith-Wiedemann Syndrome (BWS) show
biallelic expression of IGF2 that is associated with the inheritance
of maternally methylated or deleted ICRs [12].
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Although the acquisition of ICR methylation is often considered
the main imprinting ‘mark’, maintaining the unmethylated state of
ICRs is also part of an active imprint. The acquisition of ectopic
methylation by maternal Igf2/H19 ICRs with CTCF site
mutations demonstrates this concept of active maintenance of
hypomethylated ICRs [9-11,13,14]. During embryogenesis, loss of
CTCF binding at one or more of the four binding sites results in
ICR methylation in somatic cells, and biallelic transcription of Igf2
[9–11,13,14]. Conversely, mutations that allow CTCF to bind
methylated paternal ICRs have also shown that CTCF can
facilitate demethylation of the paternal allele in mouse somatic
tissue [15]. However, CTCF binding is not required for erasure of
paternal methylation imprints in primordial germ cells (PGCs) or
for protection of the ICR from de novo methyltransferases during
postnatal methylation imprint establishment in oocytes [9–11]. In
addition to CTCF, the Igf2/H19 ICR has a conserved pair of Sox-
Oct motifs located between CTCF sites 2 and 3 in mice and in
both A repeats in humans [16,17]. Both the mouse and human
motifs are comprised of a site for Sox proteins immediately
adjacent to an octamer element, which binds POU family
proteins. The motifs have been shown to bind Sox2, Oct4 and
Oct1 in vitro and can drive demethylation of partially methylated
ICR transgenes in a mouse embryonic carcinoma cell line [16,17].
Furthermore, point mutations that disrupt Oct4 binding are
associated with abnormal maternal ICR methylation in a small
number of BWS patients [18,19].
In this study, we investigated the role that the octamers within
the Sox-Oct motif play in establishing and maintaining the
maternal hypomethylation imprint of the mouse ICR. Using a
mouse with mutations in the octamers, we found that intact Sox-
Oct motifs were required to protect the maternal ICR from de novo
methylation in somatic tissues and in oocytes, but were not
essential for imprint establishment or mono-allelic expression of
H19 and Igf2. Taken together, our results suggest that the stem
cell/germline factors Sox2 and Oct4 participate in ICR
hypomethylation.
Results
CTCF and octamer sites regulate ICR DNA methylation in
F9 cells
The mouse Igf2/H19 ICR has four CTCF sites and a closely
spaced pair of Sox-Oct motifs (Sox-OctA and Sox-OctB) that lie
about 200 bases from CTCF site 2 (Fig. 1A). Previous work
indicated that CTCF and octamer sites regulate CpG methylation
of the ICR, but whether these sites collaborate is unknown [9–
11,13,16–19]. To more fully address octamer functions in the
ICR, we searched for similar sequences and found an additional
consensus octamer site 450 bp upstream of CTCF site 1 (Fig. 1A).
To determine whether the octamers and CTCF sites cooperate in
regulating ICR methylation, we mutated the three octamers and
four CTCF sites in ICR-containing plasmids and assessed the
methylation status of the transgenes after their stable incorporation
into F9, C2C12 or 3T3 cells. F9 embryonic carcinoma cells were
chosen, as they express Sox2 and Oct4, and have demonstrated
both de novo methylation and demethylation of transgenes. C2C12
and 3T3 cells, on the other hand, do not express Sox2 and Oct4.
Using methylation sensitive Southern analysis, we found that
integrated transgenes containing the wild type ICR and H19
promoter did not acquire methylation in F9 cells, while mutation
of the octamers resulted in a small amount of de novo ICR
methylation, which is shown by the incomplete digestion of the
BglII fragment with HpaII (Fig. 1A and B). In contrast to results
seen in mice, mutation of the four CTCF sites did not lead to
Figure 1. Analysis of ICR transgene methylation in F9 cells. (A)
Top: Structure of mouse ICR transgene depicting consensus octamer, O
(black oval); four CTCF sites, C1–C4 (white ovals); two Sox-Oct motifs
(striped oval). Middle: ICR sequence encompassing both Sox-Oct motifs (A
and B) and a downstream Sox site (SoxC). Nucleotides matching the
respective consensus sequences are underlined. Bottom: HhaI, and HpaII
restrictionmaps for the 2.4 kb BglII,(Bg) ICR fragment. (B–E) Southern blot
analysis of F9 genomic DNA prepared from polyclonal populations with
stably incorporated WT or mutant ICR transgenes. DNA was digested with
BglII followed by digestion with HhaI (H), HpaII (P), or MspI (M). The 2.4kb
BglII fragment was used as a probe. The endogenous ICR is visible only as
a faint signal compared to that generated by the multicopy transgene.
Each blot is representative of the data obtained from three independent
polyclonal populations. (B) Stable transfectants obtained from unmethy-
lated ICR constructs containing either a WT sequence, (wt ICR); mutations
in all four CTCF sites, (mut ctcf); mutation in the three octamer sites, (mut
oct); or in all octamer and CTCF sites (mut oct/ctcf). (C–E) All plasmids
were in vitro methylated at HhaI and HpaII sites prior to transfection. (C)
Stable transfectants obtained from the sameWT andmutant constructs as
in (B) but with in vitro methylation (D) Stable transfectants obtained from
methylated constructs with OctA or OctBmutations combined with either
WT or mutant CTCF sites. (E) Stable transfectants obtained from
methylated constructs with separate mutations in SoxA, SoxB or SoxC.
Both the mutant and WT (wt sox) constructs contain two modified SpeI
cloning sites flanking the respective Sox-Oct elements. See Table S1 for
WT and mutant sequences.
doi:10.1371/journal.pone.0081962.g001
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increased methylation of the ICR (Fig. 1B). The protective activity
of CTCF was apparent only when both the CTCF and octamer
sites were mutated, as the double mutant ICR showed less
digestion by HhaI and HpaII than the octamer mutant alone
(Fig. 1B).
In addition to protection from de novo methylation, binding by
certain transcription factors can drive demethylation of partially
methylated sequences. We tested the demethylation activity of the
CTCF and octamer sites using stably integrated plasmids that had
been treated with HhaI and HpaII methyltransferases, and found
that both WT and CTCF mutant ICRs were demethylated in F9
cells (Fig. 1C). By contrast, ICR transgenes with mutant octamers
retained most of their partial methylation. Moreover, ICR
constructs with single mutations in either OctA or OctB retained
methylation to the same degree as the double octamer mutant
(Fig. 1D). Combining CTCF and octamer mutations resulted in a
modest additional decrease in demethylation activity (Fig. 1C and
D). Transgenes containing mutations in the distal octamer showed
wild type levels of demethylation regardless of CTCF site
functionality, suggesting that it is not involved in regulating ICR
methylation (Fig. S1A).
Octamer mediated demethylation of the ICR was both specific
to embryonic carcinoma cells and limited to ICR constructs with
low density methylation. Partially methylated WT and mutant
ICR transgenes stably integrated into either mouse C2C12 or
NIH3T3 cells remained methylated (Fig. S1B), which is consistent
with a requirement for Sox2 and Oct4 for demethylation. In
addition, these results suggest that Oct1, which is expressed in F9,
C2C12 and NIH3T3 cells and can bind the ICR octamers
(Fig. 2A, 2B and data not shown), is not sufficient to drive ICR
demethylation. In contrast to partially methylated plasmids, WT
ICR transgenes fully methylated in vitro with SssI methyltransferase
remained highly methylated in F9 cells (Supplementary Material,
Fig. S1C). Thus, the presence Sox2/Oct4 is not sufficient to drive
demethylation of a completely methylated ICR in F9 cells.
Sox binding sites regulate ICR methylation in F9 cells
Octamers are often found adjacent to Sox sites, with binding of
both Sox and POU factors required to form a functional unit. We
tested the importance of the Sox binding sites in the Sox-Oct
motifs using the F9 demethylation assay and partially methylated
ICR constructs containing mutations that disrupted each Sox site
(Fig. 1E). The Sox site mutations prevented formation of a Sox2-
Oct4 ternary complex but did not alter Oct4 binding to the
adjacent octamer (Fig. 2C). Southern analysis demonstrated a
modest reduction in ICR demethylation activity when SoxA was
mutated. However, mutation of the SoxB exhibited a greater loss
in demethylation activity, which was comparable to the single
octamer mutations. We also identified a sequence (SoxC) 22 bps
downstream from Sox-OctB that bound Sox2 in vitro (Fig. 1A and
2B). Mutation of this element, however, did not affect ICR
demethylation alone or in combination with the Sox-OctA mutant
(Fig. 1E and Fig. S1D).
Oct4 and Sox2 bind cooperatively to the ICR Sox-Oct
motifs
The limited demethylation of WT transgenes in NIH3T3 and
C2C12 cells suggested that Sox2 and Oct4 binding mediates ICR
demethylation. Consistent with this idea, chromatin immunopre-
cipitations (ChIP) from F9 cells showed Oct4 and Sox2
enrichment at both the endogenous and wild type transgenic
ICRs, but not at the octamer mutant ICR (Fig. 2D). Analysis of
published data from genome-wide Oct4 and Sox2 ChIPs also
revealed that the pluripotency factors are localized to the Sox-Oct
motifs in mouse embryonic stem (ES) cells (data not shown) [20].
Furthermore, EMSAs performed with F9 nuclear extract showed
that both motifs formed heterodimeric complexes with Oct4 and
Sox2, and the same octamer mutations that disrupted ICR
demethylation also prevented Oct4 binding in vitro (Fig. 2A and
2B). A lower mobility complex, which is likely to contain the POU
factor Oct1, also was present in EMSAs with F9 nuclear extract
(Fig 2A). Thus, Oct1 or other POU factors could contribute to or
inhibit ICR demethylation. Because the Sox-Oct-dependent
demethylation in F9 cells was limited to partially methylated
transgenes, we performed EMSAs with ICR probes methylated at
all CpGs and found that the methylation did not inhibit formation
of Sox2/Oct4 complexes (Fig. 2C). SoxC, which lacked demeth-
ylation activity, produced a clear complex with Sox2 but was not
able to form a Sox2-Oct4 complex (Fig. 2B and C).
To assess the potential cooperative binding characteristics of
Oct4 and Sox2 to the Sox-Oct motifs, we performed EMSAs with
recombinant proteins and found that Oct4 bound to both
elements equally well (Fig. 2C and E). Sox2, however, bound
weakly to the WT and Sox site mutant Sox-OctB probes, and
bound to the WT and Sox site mutant Sox-OctA probes almost
equally well (Fig2C and E). Sox2’s binding to the mutant Sox-
OctA probe is likely to be through the octamer, as it contains a
Sox consensus site (data not shown). Although the ectopic binding
by Sox2 complicated our ability to measure it accurately, we were
able to demonstrate cooperative binding between Sox2 and the
Oct4-Sox-OctA complex. First, we established EMSA conditions
in which no more than 10–20% of the Sox-OctA probe was bound
by either Sox2 or Oct4 when added separately. If the two factors
bound independently, then only 1–4% of the probe would be
expected to be in a ternary complex with Sox2 and Oct4.
However, we found roughly equal amounts of binary and ternary
complexes (Fig. 2E), which when quantified indicated a 6–10 fold
enhanced binding of Sox2 to the Oct4-DNA complex (Supple-
mentary Material, Fig. S2aA). For the Sox-OctB motif, the
amount of ternary Sox-OctB complex was at least 50 fold more
than that expected from independent binding of Oct4 and Sox2
(Fig. S2A). In this case, the cooperativity was much more
pronounced as Sox2 alone bound to less than 1% of the probe
(Fig. 2E). Conserved Sox-Oct motifs in the Human ICR A2 repeat
also demonstrated cooperative binding of recombinant Sox2 and
Oct4 in EMSAs (Fig. S2B).
Given the proximity of the two Sox-Oct motifs to one another,
it was unclear if Sox2 would be occluded from binding between
the two Oct4 proteins. Using probes containing both Sox-Oct
motifs, we found that recombinant Oct4 and Sox2 were capable of
forming several complexes with the probe, including one that was
likely to represent full occupancy of both motifs (Fig. S2C).
However, this complex represented a small fraction of observed
complexes, making it difficult to confidently assign its composition.
To simplify the EMSAs, we used a human ICR A2 probe with a
mutant Sox site upstream of the first octamer. This probe showed
the formation of an Oct4-Sox2-Oct4 complex, which indicated
that there is sufficient space for Sox2 to bind between the two
Oct4 molecules (Fig. S2C).
The ICR Sox-Oct motifs activate transcription in F9 cells
The capacity of Oct4 and Sox2 to initiate DNA demethylation
along with transcriptional activation during cellular reprogram-
ming has been well established [21]. A similar correlation between
the ability to activate transcription and to drive DNA demethyl-
ation has been demonstrated for other transcription factors,
suggesting a mechanistic link between the two events.To
determine whether transcriptional activation by the ICR Sox-
Oct4/Sox2 Maintain H19/Igf2 ICR Hypomethylation
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Oct motif correlated with the demethylation seen in the stable
transfections, we placed ICR fragments containing the elements
upstream of a luciferase gene driven by the H19 promoter
(Fig. 3A). In transiently transfected F9 cells, the Sox-Oct regions
activated the reporters more than five-fold compared to the H19
promoter alone. Mutation of one or both octamers abolished
transactivation and produced a modest repression. Mutations
disrupting the SoxA and B binding sites also abolished transcrip-
tional activation. Mutating SoxC lead to a modest reduction in
luciferase expression, suggesting that this element is functional. To
determine if Oct4 was required for transactivation, we transfected
F9 cells that had been depleted of Oct4 by shRNAs and found that
relative luciferase expression dropped at least 90% compared to
control shRNA expressing cells (Fig. 3B). Consistent with the Oct4
knock-down, mouse 3T3 cells lacking endogenous Oct4 and Sox2
expression were transiently transfected with ICR-reporter con-
structs and found to have luciferase levels equal to or less than that
of H19 promoter controls (data not shown). Therefore, both
transcriptional activation in transient assays and DNA demethyl-
ation of integrated ICR transgenes appear to share similar
requirements for cooperative Oct4 and Sox2 binding to both
Sox-Oct motifs.
Octamers are required for maintenance of the
unmethylated maternal ICR in somatic cells
To determine if the octamers participated in establishing or
maintaining the ICR’s differentially methylated state in vivo, we
used homologous recombination and ES cells to create mice with
mutations in the three octamer sites (Fig. 4A and B). Southern
analysis of DNA from neonatal liver and muscle (Fig. 4C) showed
that the loss of octamer binding had no effect on the methylation
of paternally transmitted mutant ICRs. However, methylation of
maternally transmitted mutant ICRs increased significantly, as
indicated by reduced HpaII and HhaI digestion compared to wild-
type maternal ICR DNA. The asymmetric distribution of methyl-
sensitive restriction sites in the probed region (with HpaII sites
being more 59 and HhaI more 39 to the octamers) also provided a
means for assessing the relative location of methylated CpG
downstream of Sox-OctB. Analysis of the banding patterns from
HpaII and HhaI digests suggests that the majority of mutant allele
Figure 2. Sox2 and Oct4 binding to the ICR. EMSAs were performed using WT or mutant ICR probes as indicated with either F9 NE (A, B) or
recombinant Oct4 and Sox2 (C, D, F). (A) The effect of octamer specific point mutations on Oct4 and Sox2 binding was assessed by addition of
nonspecific (N) and specific unlabeled DNA competitors - oct (O), sox (S), ICR Sox-OctA and B (A and B), or mutant ICR Sox-OctA and B (mA and mB).
(B) Oct4 and Sox2 supershift assays. Sox2 and Oct4 protein-DNA complexes (white and black triangles respectively) were identified by their respective
antibodies (Ab). Presumptive Oct1 complexes are indicated by a grey triangle. (C) Recombinant Sox2 binding to Sox-OctA, B and SoxC. ICR probes
with mutations to the Sox elements (mSA, mSB, and mSC) were used to confirm Sox2 binding sites. (D) Methylation-independent binding of Oct4 and
Sox2 to the ICR Sox-Oct motifs Wild type ICR Sox-OctA and B probes (A* and B*) were methylated at all CpGs. (E) Oct4 and Sox2 ChIP assays.
Enrichment of endogenous F9 or WT and mutant transgenic ICR octamers by Oct4 and Sox2 ChIP was determined by qRT-PCR and normalized to
serum controls. Error bars represent standard deviation of the mean (n = 3). Statistical significance of Oct4 and Sox2 enrichments was shown using
Student’s t-test (*p,0.05). (F) Cooperative binding of Sox2 to Oct4 complexes. Cooperative binding characteristics of Sox2 to the ICR were assessed
by measuring the amount of binary and ternary protein-DNA complexes formed using a fixed amount of Oct4 and increasing amounts of Sox2. See
Table S1 for a complete list of probe and competitor sequences.
doi:10.1371/journal.pone.0081962.g002
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methylation was concentrated near the octamers while the region
including the promoter proximal CTCF sites was largely
unmethylated.
To more accurately characterize the increased methylation, we
performed bisulfite sequencing of the region including CTCF site
2 and the octamers on DNA from neonatal liver and found
increased CpG methylation flanking the mutant Sox-Oct motifs
consistent with the Southern analysis. On average, CpGs within
35 bps of the Sox-Oct motifs from maternally inherited mutant
alleles were 84% methylated and more than 53% methylated for
all CpGs in the fragment. In WT ICRs, CpGs within 35 bps of the
Sox-Oct motifs were 20% methylated compared to a 14% average
methylation for all CpGs in the amplified fragment (Fig. 5A). In
contrast, the three CpGs within CTCF site 2 showed a modest
31% average methylation for the mutant alleles compared to a
19% average methylation for the maternal wild-type alleles. A
comparison of WT and mutant maternal alleles from neonatal
muscle yielded similar results (Fig. S3). Additional bisulfite analysis
of the ICR region surrounding CTCF site 4 from neonatal liver
showed virtually no methylation of maternal mutant alleles
(Fig. 5A). Paternal methylation imprints were likewise unaffected
by the octamer mutations (Fig. 5A and data not shown).
Figure 3. ICR Sox-Oct motifs activate transcription in F9 cells.
(A) F9 cells were co-transfected with a b-galactosidase reporter for
normalization and an unmethylated luciferase reporter construct driven
by the H19 promoter alone or in combination with either a 352 bp or
an 83 bp ICR fragment which included WT or mutant Sox-Oct motifs
without CTCF sites. Normalized luciferase activities are shown relative to
the activity of the H19 promoter alone. (B) The effect of Oct4 shRNA
knock-down on relative luciferase activity is shown for constructs
containing either two copies of the wt 83 bp ICR fragment (wt 8362) or
the wt 352 bp fragment. S1 and S3 indicate two different Oct4 shRNAs.
SCR indicates scrambled control shRNA. ‘O4 shRNA’ includes both S1
and S3 shRNA knockdown samples. Western blot of F9 cell extract (CE)
from S1, S3 or SCR treated cells probed with a-Oct-4 and a-NPM
antibodies.
doi:10.1371/journal.pone.0081962.g003
Figure 4. Octamer mutations increase maternal ICR methyla-
tion in neonatal somatic tissues. (A) Restriction map for the H19/
Igf2 locus, targeting vector insertion and the targeted locus following
excision of the selection cassette. The neomycin resistance (neor) and
Cre recombinase (cre) genes were removed in the germline of male
chimeras by testes-specific expression of Cre. Restriction sites are AseI
(A), BamHI (B), EcorV (E), NdeI (N), and SalI (S). (B) Southern blot analysis
to confirm targeting of the mutant ICR (M.ICR) was carried out on EcorV
or NdeI digested WT and targeted ES cell DNA hybridized to 59 and 39
probes, respectively. Correct Cre-mediated excision of the selection
cassette was confirmed by BamHI and AseI-digestion of tail DNA from
F1 mice. (C) Methylation sensitive Southern blot analysis was
performed on DNA from neonatal liver and muscle from WT and
heterozygous mutant mice. Genomic DNA was digested with BamHI
and BspHI (Bs) and then HhaI (H), HpaII (P), or MspI (M). Restriction maps
of ICR are shown. The mutation in OctB created an additional BspHI
(Bs*) restriction site. The 1.4 kb mutant ICR BspHI-BamHI fragment was
used for the probe. The results shown are representative of methylation
sensitive Southern analysis performed on six pups from four different
mutant females.
doi:10.1371/journal.pone.0081962.g004
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Octamer mutations increase methylation in oocytes but
not blastocysts
To determine if the ectopic methylation of the maternal mutant
ICR occurred during oogenesis or after fertilization, we conducted
additional methylation analysis of mutant embryos, oocytes and
blastocysts (Fig. 5B–D). In somatic tissue from 12 dpc embryos,
methylation of the mutant maternal ICR appeared relatively
unchanged from methylation patterns present in neonatal tissues
(Fig. 5B). In oocytes, bisulfite sequencing of the octamer region
revealed that roughly half of the mutant ICRs exhibited
methylation patterns similar to those obtained from somatic
tissue, while the other half remained unmethylated (Fig. 5C).
However, we found the octamer region from mutant blastocysts to
be almost completely unmethylated (Fig. 5D). Although we cannot
exclude maintenance of the oocyte-derived methylation in some
animals, its absence in blastocysts suggests that maternal ICR
methylation found in later stages occurred after implantation.
The octamers are not required for establishing an
unmethylated ICR in the primordial germline
We assessed mutant ICR methylation in germ cells during
different stages of embryogenesis to determine if the ectopic
methylation in oocytes resulted from a failure to erase paternal
methylation imprints or from inadequate protection from de novo
methylation during normal imprint establishment in oocytes
[22,23]. Primordial germ cells (PGCs) were isolated from 14, 16
and 18 dpc ovaries and testes by crossing ICR mutants with a
Pou5f1-EGFP strain and FACS sorting the respective dissociated
tissues. 94–99% of GFP+ FACS isolated cells tested also stained
positive for alkaline phosphatase (data not shown). Bisulfite
analysis of PGCs from 14 dpc ovary and testes showed normal
hypomethylation of maternally inherited mutant ICRs (Fig. 6).
The ICR octamers also were not required for erasure of paternal
methylation in female PGCs as evidenced by the absence of
methylation on paternally derived mutant alleles from 16 dpc
ovaries. Moreover, no de novo methylation of the mutant octamer
region was seen in the female germline up to and including 18 dpc
development. In embryonic testes, mutant alleles acquired
paternal specific methylation imprints irrespective of parental
origin (Fig. 6).
The ICR octamers have little influence on mono-allelic
expression of H19 and Igf2
We performed a single nucleotide primer extension assay
(SNuPE) in order to determine if the methylation observed on the
maternal mutant ICR was sufficient to alter the normal allelic
expression ratios of H19 and Igf2 in liver, muscle, tongue, kidney,
and brain from neonatal wild type and heterozygous mutant mice.
Despite the partial methylation of mutant ICRs in liver and
muscle, no significant difference in the ratio of maternal/paternal
H19 allelic expression was observed for the maternally transmitted
mutant alleles (Fig. 7A). The ratio of paternal to maternal Igf2
expression was similarly unchanged in all tissues assayed except for
kidney where we observed an apparent 2.5 fold increase in
maternal Igf2 expression (Fig. 7B). We observed no difference in
size between neonatal mice that inherited the mutant maternal
allele and their WT littermates, which was consistent with normal
repression of maternal Igf2 in most tissues (data not shown).
Discussion
Genomic imprinting requires establishing and maintaining
DNA methylation on one ICR allele and the absence of
methylation on the other. At the Igf2/H19 locus, CTCF binding
maintains the maternal ICR in its unmethylated state, but only
after fertilization [9–11]. However, it is unknown if other DNA
binding factors cooperate with CTCF in the early embryo or if
germline factors establish hypomethylation in oocytes. We found
that Oct4 and Sox2 bind cooperatively to the two Sox-Oct motifs
and that both the Sox and Oct site within each motif are required
for robust ICR demethylation in F9 cells, suggesting they comprise
a single functional unit capable of driving DNA demethylation.
Hori et al. showed a similar requirement for both Sox-Oct
elements to drive ICR demethylation in P19 cells [17]. We made
mice with mutations in the Oct4 elements and found increased
maternal ICR methylation after the blastocyst stage and minor
methylation increases in oocytes. Thus, the Sox-Oct motifs
participate in both establishing a hypomethylated ICR in oocytes
and maintaining this state after fertilization. This activity is most
pronounced in the maintenance phase and is likely to prevent
methylation during the wave of genome-wide remethylation that
occurs after implantation [24]. However, unlike the CTCF site
mutations, the extent of ectopic methylation was insufficient to
cause loss of Igf2 imprinting, indicating that CTCF plays a greater
role than Oct4/Sox2 in maintaining ICR hypomethylation in
somatic cells.
Figure 5. Methylation profiles of WT and mutant ICRs. Each
horizontal line of circles represents a unique sequence.
Unmethylated and methylated CpGs are presented as open and closed
circles, respectively. Multiples of the same methylation pattern are
indicated to the right of each sequence. Lines above the circles indicate
relative location of CTCF sites 2 and 4 (C2, C4) and the Sox-Oct motifs
(SO). The mutant status and the allelic parent of origin are indicated to
the upper left of each block of sequences. (A) Bisulfite analysis was
performed on neonatal liver from three heterozygous mutant mice and
(B) the maternally transmitted mutant ICRs from one 12 dpc embryonic
liver. (C) Both WT and mutant bisulfite PCR products from oocytes were
the result of four separate reactions each using the DNA from 10–20
oocytes. Oocytes were collected from a combination of homozygous
and heterozygous mutant and WT females after superovulation. Each
PCR product was cloned separately, and 3–6 clones of each were
sequenced. Identical sequences from each product were counted only
once. (D) Bisulfite analysis of maternally derived mutant alleles from
heterozygous blastocysts was the result of two separate reactions of 6–
10 blastocysts each. PCR products from each reaction were cloned
separately.
doi:10.1371/journal.pone.0081962.g005
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Although these results suggest that Oct4/Sox2 and CTCF
cooperate to maintain full ICR demethylation, the activities of
each factor differed when examined in mice and F9 cells. In mice,
the ectopic methylation elicited by the Oct4 site mutations largely
centered on the Sox-Oct motif but spread to a lesser degree into
CTCF site 2. Moreover, there was no increase in methylation near
CTCF sites 3 and 4. This limited spreading of methylation might
indicate that protection by Oct4/Sox2 is due to a steric hindrance
mechanism or that CTCF limits methylation spreading. In F9
cells, however, the Sox-Oct motif drove demethylation throughout
the ICR, which suggests that Oct4 and Sox2 can actively direct
DNA demethylation using a mechanism that goes beyond simple
steric hindrance and can protect the entire ICR. With CTCF, we
found the reciprocal. In F9 cells, the CTCF sites provided little
demethylation or methylation protection activity without the Sox-
Oct motifs. In mice, however, maternal transmission of an ICR
with four mutant CTCF sites resulted in substantial methylation
across the ICR [9]. Moreover, CTCF drove substantial demeth-
ylation over the entire paternal ICR in mice with mutations that
allow CTCF to bind its sites even when methylated [15]. For this
mutant ICR, it is important to note that the CTCF site-dependent
demethylation may require cooperation with the Sox-Oct motifs,
and only local demethylation might be seen if they were also
mutated.
There are many possible explanations for the differences
between the local and long-range activity of these factors in mice
and F9 cells, especially given the complicated nature of active and
passive demethylation and de novo versus maintenance methylation.
They could simply reflect the mechanistic differences between
demethylation and blocking methylation in a multicopy transgene
array in F9 cells and at the endogenous locus in the mouse.
Alternatively, differences in the transcriptional activity of Oct4/
Sox2 and CTCF could explain the discrepancies. Transcriptional
activation is known to correlate with DNA demethylation, and
strong activators such as VP16 can induce greater long-range
demethylation than weaker ones [25]. We found a similar
correlation with long-range demethylation and transcriptional
activation by the Sox-Oct motifs in F9 cells. CTCF can activate
transcription [26], but only weakly, and it may be insufficient to
target long-range demethylation in F9 cells. In mice, however,
Figure 6. Methylation profiles of WT and mutant ICRs from female and male embryonic germ cells. Bisulfite sequencing of the CTCF site
2 and Sox-OctA and B region are shown for germ cells isolated from 14, 16, and 18 dpc ovaries and testes from heterozygous mutant embryos. WT
and mutant alleles are denoted by white and grey backgrounds respectively. The parental origin of alleles is indicated by the symbol to the left of
sequence graphical representations. Each block of bisulfite sequences was the result of 1–2 separate PCR reactions performed with DNA from 16103–
16104 GFP-sorted germ cells obtained from 4–16 pooled gonads. DNAs from separate PCR reactions were cloned separately.
doi:10.1371/journal.pone.0081962.g006
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CTCF may recruit factors that are not active in cultured cells.
Whether the protection or demethylation activity of either of these
factors involves recruiting demethylases or blocking DNA meth-
yltransferases remains to be determined.
In contrast to our results with octamer mutations, mice
possessing a ,0.9 kb ICR deletion between CTCF sites 2 and
3, which removes the Oct-Sox pair, did not show ectopic
methylation of maternally inherited mutant ICRs [27]. The
discrepancy between the point mutation and deletion alleles
suggests that the spread of methylation into CTCF site 2 that we
detected requires the sequence surrounding the Sox-Oct element.
Thus, this region could contain binding sites for methylation
nucleating factors, such as Zfp57 or other repressors [28]. If this
region has methylation nucleating activity, then the Sox-Oct sites
could counter the effects of these putative repressors. In this model,
deleting this region would be neutral, as both methylation and
demethylation activities would be removed. Consistent with
potential repressor activity, we observed that luciferase reporters
containing octamer mutations in the context of a 352 bp ICR
fragment averaged a near 2-fold reduction in expression compared
to the H19 promoter alone (Fig. 3A). In female mice, resetting the
Igf2/H19 ICR imprints requires removing methylation from the
paternal ICR during a genome-wide demethylation event in
PGCs. We supposed that this demethylation, at least in part, could
be directed to the ICR by the Oct4/Sox2 (or related factors)
present in PGCs. However we did not see any defects in
demethylation in our mutant, indicating that the Sox-Oct motif
is not required for paternal imprint erasure. Moreover, the
absence of any erasure defects in both the octamer and CTCF site
mutants [9,10] suggests that the ICR demethylation process in
PGCs is largely sequence independent.
After global demethylation in PGCs, genome-wide remethyla-
tion begins at about 16 dpc in the germline of males. In oocytes,
remethylation begins a few days after birth and continues during
maturation [22]. In males, methylation of the Igf2/H19 ICR
seemed unperturbed by the octamer mutations, whereas in females
the octamer motifs block de novo methylation of the Sox-Oct motifs
in a subset of mature oocytes. The ectopic methylation in mature
oocytes suggests that Oct4/Sox2 or related factors might protect
the Igf2/H19 ICR from Dnmt3L-dependent activity that leads to
methylation of ICRs from maternally imprinted genes [22].
Whether this methylation is sufficient to constitute a stable imprint
remains to be determined. The absence of ICR methylation in the
pooled blastocysts, however, is consistent with the loss of oocyte-
derived methylation during the post-fertilization genome-wide
demethylation.
The incomplete methylation of the mutant maternal ICRs in
both somatic and germline cells indicates that additional factors
cooperate with Oct4/Sox2. While it seems clear that CTCF and
Sox-Oct sites cooperate to protect the ICR in somatic cells, the
evidence for this activity in oocytes is somewhat equivocal. On one
hand, mutation of the CTCF binding sites does not lead to ICR
methylation in oocytes [9–11], while partial ICR methylation was
seen in oocytes depleted of CTCF [13]. In any case, cooperation in
the germline could be addressed with a double CTCF site and
octamer mutant ICR. In this regard, we found that in F9 cells
CTCF’s methylation protection activity was best demonstrated in
conjunction with the octamer mutations.
In five different cases of BWS, point mutations or a deletion
affecting one of the octamers in the human ICR has been
implicated in loss of IGF2 imprinting due to ectopic maternal ICR
methylation [18,19]. The mouse model presented here provides
direct evidence that maternal transmission of octamer mutations
alone can result in partial methylation of the maternal Igf2/H19
ICR. However, in contrast to the BWS cases, the increase in ICR
methylation induced by the mutant octamer was mostly absent
from the CTCF sites of maternally inherited alleles, indicating that
most sites remained occupied by CTCF. This conclusion is
consistent with our finding that imprinted expression of H19 and
Igf2 was largely unaffected. The differences between the effects in
mice and humans suggest that the control of methylation by the
conserved octamers may depend on non-conserved aspects of ICR
architecture or species-specific differences in DNA methylation
machinery. The existence of species-specific requirements for
methylation maintenance is suggested by the inability of paternally
inherited human ICR transgenes to maintain methylation that was
acquired during spermatogenesis [29]. Alternatively, octamer
mutations may not be fully penetrant for substantial ICR
methylation in humans. Thus, the octamer-dependent BWS cases
could represent mutant individuals that were also subject to a
stochastic methylation event, or that have genetic polymorphisms
that increase DNA methylation.
Protecting hypomethylation imprints of ICRs may be a
common function of Oct4 and Sox2 at imprinted loci. For
example, the normally hypomethylated human Angelman Syn-
drome – imprinting center (AS-IC) acquires methylation in mouse
oocytes when mutations are made in one of two octamers or an
independent Sox site [30]. Similar to the mutant H19/Igf2 ICR,
methylation in oocytes occurs on only a fraction of mutant alleles
and is lost during fertilization. The AS-IC also has binding sites for
Figure 7. Allelic H19 and Igf2 mRNA expression ratios in
neonatal mice. SNuPE analysis was carried out on (A) H19 and (B)
Igf2 cDNA from 4 dpn heterozygous mice having a paternally inherited
WT M. cast. allele and a maternally inherited WT or mutant B6 allele. The
ratio of transcript for each tissue was determined by averaging the
individual allelic ratios for 3–5 different mice. Error bars represent the
standard deviation of the mean. The p values were generated using
Student’s t-test.
doi:10.1371/journal.pone.0081962.g007
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other factors that regulate its methylation [30], which parallels the
partial redundancy between CTCF and Oct4/Sox2 at the ICR. In
addition to these two loci, we analyzed published genome-wide
ChIP data and found that Sox2 and Oct4 also occupied several
ICRs from other imprinted loci in ES cells (data not shown).
Taken together, these results suggest that Oct4 and Sox2 (or
related factors) may collaborate with other transcription factors to
establish ICR hypomethylation at several imprinted loci during
gametogenesis and then maintain that hypomethylation after
blastocyst implantation. Although their function needs to be
addressed further, the possibility that factors key to germline and
stem cell development participate in setting and maintaining
imprints reveals an intimate connection between these processes




Mutations in the ICR were created using overlapping PCR with
mutant primers. Substitutions at OctB and the upstream octamer
(23248 and 24338 with respect to the H19 start site) created
novel BspHI sites. The 1.5 kb mutant PCR products were ligated
into the XhoI and BspEI sites of a pcDNA3-luciferase vector
containing the mouse H19 upstream region (from 25547 to +695)
with either WT or mutant CTCF sites. WT and mutant Sox
constructs were prepared by replacing the octamer region from
23305 to 23209 in the same pcDNA3 vector containing the
mouse H19 upstream region with a unique SpeI site via
overlapping PCR. WT and mutant 83 bp sequences correspond-
ing to the deleted region were constructed by ligating three
double-strand oligonucleotides containing the appropriate muta-
tions into a SpeI linearized vector. (See Table S1 for WT and
mutant sequences.)
Luciferase reporter constructs were prepared by inserting either
a 352 bp WT or mutant octamer PCR product (23396 to 23044)
or the 83 bp WT or mutant Sox sequence into the NheI site of the
pH19-Luc vector [26]. All PCR-derived constructs were se-
quenced to ensure fidelity.
Oct4 and Sox2 recombinant protein expression vectors were
prepared by cloning BamHI – SalI fragments containing the
respective cDNAs from pMXS-Oct3/4 and pMXS-Sox2 (Ad-
dgene plasmids 13366 and 13367 [31]) into the BamHI site of
pET-15b (Novagen).
The mutant octamer knock-in vector was prepared by ligating
the mutant ICR contained within an XbaI fragment from 25.5 to
20.8 kb between the lox511 and loxP sites of a previously
described targeting vector [9].
Cell culture and stable transfection
F9, NIH-3T3, C2C12, and HEK293T cells (all from ATCC)
were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) and penicillin-
streptomycin. F9 cells were cultured on 0.1% gelatin-coated
dishes. For ICR demethylation analysis, constructs were treated
with HhaI and HpaII methyltransferases for partial methylation
and SssI methyltransferase for full CpG methylation. Complete
methylation was verified by HhaI and HpaII restriction digest
followed by agarose gel electrophoresis and ethidium bromide
staining. Only DNA showing no digestion was used in transfec-
tions. Cells were co-transfected with test constructs and either a
pcDNA3.1 or pBS-puromycin selection plasmid at a ratio of 5:1
using either FuGENE 6 [30] or MirusTransIT-LT1 at a
lipofectant to plasmid ratio of 3:1. Cells underwent 10 days of
selection with either G418 or puromycin and were then passaged
onto 60 mm plates and harvested when confluent.
Luciferase assays
Transient transfections of F9 cells were performed in six well
plates using 3 mL MirusTransIT-LT1 and 0.5 mg each of test
construct and pSV-b-gal (Promega). After 48 hours, cells were
harvested in Reporter Lysis Buffer (Promega), and b-galactosidase
and luciferase activity were assayed as previously described [32].
Relative luciferase expression was calculated after normalizing for
b-galactosidase activity. Student’s t-test was used to determine
statistical significance of at least three independent transfections.
Lentivirus-mediated Knockdown
Knock-down of Oct4 in F9 cells was achieved using lentiviral
particles derived from Sigma-Aldrich MISSION plasmids
pLKO.1, (S1= Clone ID: NM_013633.1-659s1c1, and S3=
Clone ID: NM_013633.1-544s1c1). A pLKO.1 vector with a non-
targeting shRNA (SCR= Sigma-Aldrich SHC002) served as a
negative control. Lentivirus was produced in 293T cells and used
to infect F9 cells on a 6-well plate according to the Addgene
pLKO.1 Protocol version 1.0 (December 2006). F9 cells under-
went selection with puromycin from 25248 hrs post-infection and
then were passaged onto a 6-well plate. At 72 hrs post-infection,
cells were transfected with luciferase vectors and pSV-b-gal and
then collected for analysis after 48 hrs. Oct4 knock-down was
verified by Western blotting extracts from cells infected in parallel
and collected 5 days post-infection using rabbit a-Oct4 [Santa
Cruz sc-9081 (1:500 dilution)] and mouse a-nucleophosmin
(NPM) [LabVision ms-1849 (1:10,000)]. HRP-conjugated human
a-rabbit IgG [Sigma-Aldrich A0545 (1:5,000)] and goat a-mouse
IgG [Jackson ImmunoResearch 63656 (1:8,000)] secondary
antibodies. Blots were visualized using Peirce SuperSignal West
Pico Chemiluminescent Substrate.
Southern blotting
To assess ICR methylation, genomic DNA was purified as
previously described and digested with BglII followed by HhaI or
HpaII methyl-sensitive restriction enzymes [9]. MspI, a methyla-
tion insensitive isoschizomer of HpaII, was used as a positive
control for complete digestion. Digested DNA was separated by
agarose gel electrophoresis followed by blotting to Hybond-XL
(Amersham Biosciences). Probes were radiolabeled with the
Takara Random Primer DNA Labeling Kit and hybridized to
membranes in either Rapid-Hybe Buffer (GE Healthcare)
supplemented with 25 mg/ml salmon sperm (SS) DNA at 65uC
for 2 hrs or 3% Poly(acrylic acid) pH8.0, 66 SSPE, 1% SDS,
0.1% BSA, 25 ug/ml SS DNA at 65uC overnight. After
hybridization membranes were washed in 26 SSC, 0.1% SDS
at room temperature for 2 min, twice in 16 SSC, 0.1% SDS at
65uC for 15 min, and once in 0.16 SSC, 0.1% SDS at 65uC for
30 min.
Electrophoretic mobility shift assays
F9 nuclear extract (NE) was prepared as previously described
[33]. Recombinant Oct4 and Sox2 were purified from IPTG
induced Rosetta (DE3) pLys competent cells (Novagen) trans-
formed with pET-15b-Oct4 or pET-15b-Sox2 expression vectors
and cultured in LB supplemented with ampicillin and chloram-
phenicol. After lysis with BugBuster Protein Extraction Reagent
(Novagen), Oct4 and Sox2 were purified from inclusion bodies by
preparative SDS-polyacrylamide gel electrophoresis. Isolation and
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renaturation of the gel-isolated proteins were performed according
to Hager and Burgess [34].
Oligonucleotide probes and competitors used in EMSA are
listed in Table S1. For each reaction 25 fmoles of labeled double-
stranded probe was incubated for 10 min at room temperature
with either F9 NE or recombinant Oct4 and/or Sox2 proteins in a
16 ml reaction buffer containing 10 mM Tris pH8.0, 2 mMMgCl,
100 mM KCl, 1.25 mM DTT, 5% glycerol, 0.0625% BSA, and
19 mg/ml dGdC. Supershifts included an additional 10 min RT
incubation with 1 mg of anti-Oct4 (Santa Cruz sc-9081), anti-Sox2
(Santa Cruz sc-20088), or IgG (Santa Cruz sc-2028) as a negative
control. Reactions were separated on a 4% 0.25X TBE
polyacrylamide gel at room temperature, which was dried before
exposing to film. Quantitative analysis of DNA binding data was
performed using a Storm 860 Phosphoimager and ImageQuant
5.2 software.
Chromatin immunoprecipitations (ChIP)
Chromatin from F9 and F9 stable transfectants was prepared
and immunoprecipitated using the ChIP-IT Express kit (Active
Motif). Chromatin was cross-linked at room temperature with
either 1% formaldehyde for 10 min or 2 mM disuccinimidyl
glutarate (DSG) 45 min followed by formaldehyde for 10 min
(Sox2 endogenous ICR precipitations only) and sonicated using a
Vibra Cell (VC 375) ultrasonic processor. Each ChIP reaction
contained 25 mg of sheared chromatin precipitated with 6ug anti-
Oct4 (Santa Cruz sc-9081), 6 mg anti-Sox2 (3 mg each of Santa
Cruz sc-20088 and sc-17320) or 6 mg IgG (Santa Cruz sc-2028
and sc-2027) as a negative control. Precipitated DNA was
analyzed using a two-step qRT-PCR reaction in SsoFast Eva-
Green Supermix (Bio Rad) on a Bio Rad iCycler. The primers
used to amplify the ICR octamer region are: 59-ATGCAGACCC-
CACTAAGCAT-39 and 59-CGGAGATCATTAGCATCTGA-
39.
Generation of transgenic mice
ES cell lines and chimeric mice were created by the University
of Illinois Transgenic Mouse Facility. CJ7 cells [35] were
electroporated with SalI linearized knock-in vector and colonies
were selected for G418-resistance. ES clones demonstrating proper
targeting by Southern analysis were injected into C57BL/6J (B6)
derived blastocysts. Genotyping and confirmation of Cre-mediated
deletion of the neo cassette were performed by Southern analysis
and PCR of tail DNA (MOPrimer, 59- ATCATTGGGGCGTT-
CAGATAATC-39 and OCR3, 59-GACAGTGCAAAACAGGT-
GAA-39). All experiments involving animal were conducted in
accordance with protocols approved by the Animal Care and Use
Committee at the University of Illinois at Urbana-Champaign for
the purposes of minimizing animal suffering (IACUC Protocol
#9250).
Oocyte and blastocyst isolation
Unfertilized oocytes were collected from the oviducts of
superovulated mice approximately 18 h after hCG was adminis-
tered. The oocytes were incubated in hyaluronidase to dissociate
the cumulus cell-oocyte complexes and then visually sorted and
inspected to eliminate cumulus cell contamination. Expanded
blastocysts were collected from the uteri of superovulated females
84-90 h after hCG injection and mating. All blastocysts were
sorted and visually inspected to eliminate contaminating cells and
debris.
Germ cell isolation
Embryos for PGC isolation were obtained from matings
between mutant ICR mice and B6;CBA-Tg (Pou5f1-EGFP)
[36]. Embryos were sexed and staged according to morphology
[37]. Embryonic gonads were separated from the mesonephros,
digested with 150 ml of trypsin-EDTA [0.2% trypsin, 1 mM
EDTA, 16 phosphate-buffered saline (PBS)] for 15 min at 37uC,
washed with DMEM supplemented with 10% fetal bovine serum
and manually triturated to a single cell suspension using a 1 ml
syringe and 30G needle. GFP-positive cells were isolated by flow
cytometry on a BD Biosciences LSR II. PGC purity was verified
by assaying for alkaline phosphatase activity using the Vector Blue
Phosphatase Substrate Kit III (Vector Laboratories).
Bisulfite sequencing
Genomic DNA from PGCs, oocytes, and blastocysts was
prepared and bisulfite treated using the EZ DNA Methylation-
Direct Kit (Zymo Research) according to the manufacturer’s
instructions. Genomic DNA from neonatal liver and muscle was
prepared separately and added directly to the conversion reagent.
Primers (Bi3000F and Bi3455R) and PCR conditions for
amplification of CTCF site 4 were as previously described [9].
Amplification of CTCF site 2 and the octamer region were
performed using the following primer set: Bi1825F, 59-
TTGTAAAGAATTTTTTGTGTGTAAAG-39 and Bi2310R,
59-ATACAATTTCAAAATTATTTACAACCC-39. PCR was
performed for 35240 cycles under the following conditions:
95uC, 30 s; 52uC 40 s; 72uC, 100 s. For oocytes, a secondary
PCR with 125 ml of the first reaction was performed for 35
cycles with the same parameters. PCR products were gel-purified
and cloned following the manufacture’s protocol (pGEM-T,
Promega). Sequence analysis was performed using BISMA
software [38].
RNA isolation and SNuPE analysis
Tissue was dissected from WT and mutant 4 dpn pups obtained
from mating female mice heterozygous for the mutant ICR with
males that were homozygous for the M. casteneus Igf2/H19 locus.
RNA was purified using the RNeasy Mini Kit (Qiagen), and all
samples were subjected to on-column DNase digestion (RNase-
Free DNase Set, Qiagen). Tissue was homogenized for 3 min in
RLT buffer using 0.1 mm Zirconia/Silica beads and a Mini-
BeadBeater (Biospecs Products). Igf2 and H19 transcripts were
amplified using the SuperScript First Strand Synthesis System
(Invitrogen), and the following primer sets: Igf2-168F/U, 59-
ACGTGTCTACCTCTCAGGCCGTACT-39 and Igf2-166R,
59-GGGTTGTTTAGAGCCAATCAA-39 [39]; H19-172F, 59-
GCACTAAGTCGATTGCACTGG-39and H19-172R, 59-
GCCTCAAGCACACGGCCACA-39 [40]. PCR was performed
for 35 cycles under the following conditions: (Igf2) 95uC, 20 s;
53uC 20 s; 72uC, 30 s; and (H19) 95uC, 20 s; 56uC 20 s; 72uC,
20 s. Control reactions lacking RT did not yield a PCR product.
SNuPE was performed as previously described [41] using the
following primers: Igf2-169R/S, 59-TCAAATTTGGTTTTTTA-
GAA-39 [39]; H19-173R/S, 59-GGCAGCATTGCCAAA-
GAGG-39 [39]. Quantification of SNuPE reactions following
electrophoresis was performed using a Storm 860 Phosphoimager
and ImageQuant 5.2 software.
Supporting Information
Figure S1 Methylation sensitive Southern analysis of
WT and mutant ICR transgenes in F9, C2C12 and 3T3
mouse cell lines. ICR constructs and assays were identical to
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those described in Fig. 1 except where indicated. All transgenes
were either partially (HhaI and HpaII) or fully methylated (SssI)
prior to transfection. (A) Transgenes with mutations in the octamer
upstream of CTCF site 1 (shown in Fig. 1A) alone or in
combination with CTCF site mutations were stably incorporated
in F9 cells. (B) WT and mutant ICR transgenes were stably
incorporated in C2C12 cells and 3T3 cells (C) The fully
methylated WT ICR transgene was stably incorporated in F9
cells. (D) An ICR transgene containing mutations at both SoxA
and SoxC was stably incorporated into F9 cells. See Table S1 for
WT and Mutant sequences.
(TIF)
Figure S2 EMSAs with WT Sox-Oct probes for mouse
and human ICR conducted with recombinant Oct4 and
Sox2. (A) Quantitative analysis of DNA binding data from
Fig. 2E. The amount of probe in each protein-DNA complex is
represented as the percentage of total probe (bound and unbound)
for each sample. The predicted percentage of Sox2-Oct4 ternary
complex was determined by multiplying the fraction of probe
bound by Oct4 in the absence of Sox2 and the fraction of probe
bound by Sox2 in the absence of Oct4 (EMSA not shown). (B)
Probes containing conserved Sox-Oct motifs from the Human
ICR A2 repeat were incubated with Sox2 and increasing amounts
of Oct4. (C) Probes containing both mouse Sox-OctA and B or
human OctA and Sox-OctB of the Human A2 repeat were
incubated with Sox2 and increasing amounts of Oct4. Probe
sequences are listed in Table SI.
(TIF)
Figure S3 Bisulfite analysis of WT and mutant mater-
nally transmitted ICRs from neonatal muscle. Bisulfite
sequencing was performed on DNA isolated from the leg muscle of
two different 4 dpn pups (one each for WT and mutant) resulting
from reciprocal crosses of mice possessing the WT cast. and mutant
B6 allele. A polymorphism on the WT cast.allele eliminates a single
CpG located between the two octamer sites.
(TIF)
Table S1 EMSA oligonucleotides.
(TIF)
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